Clinical Trials Browser

Phase 2 × IMM-101 × Dermatologic × Clear all

NCT03711188 2024-04-29

A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma

Phase 2 Completed

16 enrolled 14 charts

Melanoma